Influence of sex on the persistence of different classes of targeted therapies for psoriatic arthritis: a cohort study of 14 778 patients from the French health insurance database (SNDS)
Influence of sex on the persistence of different classes of …
To increase detection of IMIDs drugs-related adverse events of interest and risk factors
Adverse events associated with JAK inhibitors in 126,815 reports from the WHO pharmacovigilance database
Adverse events associated with JAK inhibitors in 126,815 reports from …
Psoriasis-related treatment exposure and hospitalization or in-hospital mortality due to COVID-19 during the first and second wave of the pandemic: cohort study of 1 326 312 patients in France
Psoriasis-related treatment exposure and hospitalization or in-hospital mortality due to …
Paradoxical reactions and biologic agents: a French cohort study of 9 303 patients
Paradoxical reactions and biologic agents: a French cohort study of …
Paradoxical reactions and biologic agents: a French cohort study of 9 303 patients Lire la suite »
Association Between Biologics Use and Risk of Serious Infection in Patients With Psoriasis
Association Between Biologics Use and Risk of Serious Infection in …
Risk of major adverse cardiovascular events in patients initiating biologics/apremilast for psoriatic arthritis: a nationwide cohort study
Risk of major adverse cardiovascular events in patients initiating biologics/apremilast …
Risk of inflammatory bowel disease in patients with psoriasis, psoriatic arthritis and ankylosing spondylitis initiating interleukin 17 inhibitors: a nationwide population-based study using the French national health data system
Background Sex differences in phenotype presentation, disease trajectory and treatment …